Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial)

American Journal of Cardiology

Volumn 108, Issue 10, 2011, Pages 1387-1394

  Goto, Kenji ^a   Nikolsky, Eugenia ^a   Lansky, Alexandra J ^a   Dangas, George ^b   Witzenbichler, Bernhard ^c   Parise, Helen ^a   Guagliumi, Giulio ^d   Kornowski, Ran ^e   Claessen, Bimmer E ^a   Fahy, Martin ^a   Mehran, Roxana ^b   Stone, Gregg W ^a  

^a Department of Medicine   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d OSPEDALI RIUNITI   (Italy)

^e RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL;

ADULT; AGED; ARTICLE; BARE METAL STENT; BLEEDING; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTITHROMBINS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HEMORRHAGE; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PACLITAXEL; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PYRIDINES; RECOMBINANT PROTEINS; SMOKING; STENTS;

EID: 84860392004     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.06.063     Document Type: Article

References (23)

1. R. Mehran, B. Brodie, D.A. Cox, C.L. Grines, B. Rutherford, D.L. Bhatt, G. Dangas, F. Feit, E.M. Ohman, H. Parise, M. Fahy, A.J. Lansky, and G.W. Stone The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale Am Heart J 156 2008 44 56 (Pubitemid 351862292)
2. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
3. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
4. World Health Organization Nutritional anaemias Report of a WHO scientific group World Health Organ Tech Rep Ser 405 1968 5 37
5. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
6. G.I. Barbash, J. Reiner, H.D. White, R.G. Wilcox, P.W. Armstrong, Z. Sadowski, D. Morris, P. Aylward, L.H. Woodlief, and E.J. Topol Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries J Am Coll Cardiol 26 1995 1222 1229
7. G. Weisz, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, G. Guagliumi, T.D. Stuckey, B.D. Rutherford, R. Mehran, E. Aymong, A. Lansky, C.L. Grines, and G.W. Stone Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarctionthe smoker Am Heart J 150 2005 358 364 (Pubitemid 41116264)
8. G.J. Mishkel, A.L. Moore, S. Markwell, and M.E. Shelton Correlates of late and very late thrombosis of drug eluting stents Am Heart J 156 2008 141 147
9. S.G. Ellis, A. Colombo, E. Grube, J. Popma, J. Koglin, K.D. Dawkins, and G.W. Stone Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a Taxus II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years J Am Coll Cardiol 49 2007 1043 1051 (Pubitemid 46357591)
10. P.H. Levine An acute effect of cigarette smoking on platelet function A possible link between smoking and arterial thrombosis Circulation 48 1973 619 623
11. J.J. Belch, B.M. McArdle, P. Burns, G.D. Lowe, and C.D. Forbes The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers Thromb Haemost 51 1984 6 8 (Pubitemid 14159188)
12. J. Hung, J.Y. Lam, L. Lacoste, and G. Letchacovski Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin Circulation 92 1995 2432 2436
13. K.P. Bliden, J. Dichiara, L. Lawal, A. Singla, M.J. Antonino, B.A. Baker, W.L. Bailey, U.S. Tantry, and P.A. Gurbel The association of cigarette smoking with enhanced platelet inhibition by clopidogrel J Am Coll Cardiol 52 2008 531 533
14. S. Matetzky, B. Shenkman, V. Guetta, M. Shechter, R. Bienart, I. Goldenberg, I. Novikov, H. Pres, N. Savion, D. Varon, and H. Hod Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
15. N.R. Desai, J.L. Mega, S. Jiang, C.P. Cannon, and M.S. Sabatine Interaction between cigarette smoking and clinical benefit of clopidogrel J Am Coll Cardiol 53 2009 1273 1278
16. M.J. Price, K.R. Nayak, C.M. Barker, D.E. Kandzari, and P.S. Teirstein Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention Am J Cardiol 103 2009 1339 1343
17. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold, and R. Virmani Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
18. T.F. Lscher, J. Steffel, F.R. Eberli, M. Joner, G. Nakazawa, F.C. Tanner, and R. Virmani Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications Circulation 115 2007 1051 1058 (Pubitemid 46328299)
19. D.E. Newby, R.A. Wright, C. Labinjoh, C.A. Ludlam, K.A. Fox, N.A. Boon, and D.J. Webb Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction Circulation 99 1999 1411 1543
20. R.S. Barua, J.A. Ambrose, L.J. Eales-Reynolds, M.C. DeVoe, J.G. Zervas, and D.C. Saha Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation J Am Coll Cardiol 39 2002 1758 1763 (Pubitemid 34595285)
21. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, and A. Colombo Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
22. L.K. Newby, N.M. LaPointe, A.Y. Chen, J.M. Kramer, B.G. Hammill, E.R. DeLong, L.H. Muhlbaier, and R.M. Califf Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease Circulation 113 2006 203 212
23. J.A. Spertus, R. Kettelkamp, C. Vance, C. Decker, P.G. Jones, J.S. Rumsfeld, J.C. Messenger, S. Khanal, E.D. Peterson, R.G. Bach, H.M. Krumholz, and D.J. Cohen Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809 (Pubitemid 44305292)